These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11466662)

  • 1. The emerging role of omega-3 polyunsaturated fatty acids in the management of patients with IgA nephropathy.
    Donadio JV
    J Ren Nutr; 2001 Jul; 11(3):122-8. PubMed ID: 11466662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acids ameliorate proteinuria but not renal function in IgA nephropathy: a meta-analysis of randomized controlled trials.
    Chou HH; Chiou YY; Hung PH; Chiang PC; Wang ST
    Nephron Clin Pract; 2012; 121(1-2):c30-5. PubMed ID: 23095320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease.
    Fassett RG; Gobe GC; Peake JM; Coombes JS
    Am J Kidney Dis; 2010 Oct; 56(4):728-42. PubMed ID: 20493605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy.
    Donadio JV; Larson TS; Bergstralh EJ; Grande JP
    J Am Soc Nephrol; 2001 Apr; 12(4):791-799. PubMed ID: 11274240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of IgA nephropathy with chronic renal failure].
    Pozzi C
    G Ital Nefrol; 2008; 25 Suppl 44():83-7. PubMed ID: 19048591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of fish oil/omega-3 fatty acids in the treatment of IgA nephropathy.
    Donadio JV; Grande JP
    Semin Nephrol; 2004 May; 24(3):225-43. PubMed ID: 15156528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy?
    Donadio JV; Bergstralh EJ; Bibus DM; Grande JP
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):933-9. PubMed ID: 17699310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.
    Donadio JV; Bergstralh EJ; Offord KP; Spencer DC; Holley KE
    N Engl J Med; 1994 Nov; 331(18):1194-9. PubMed ID: 7935657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary fish oil supplementation in IgA nephropathy: a therapy in search of a mechanism?
    Grande JP; Donadio JV
    Nutrition; 1998 Feb; 14(2):240-2. PubMed ID: 9530656
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of fish oil to treat patients with immunoglobulin a nephropathy.
    Donadio JV
    Am J Clin Nutr; 2000 Jan; 71(1 Suppl):373S-5S. PubMed ID: 10618000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy.
    Donadio JV; Bergstralh EJ; Grande JP; Rademcher DM
    Nephrol Dial Transplant; 2002 Jul; 17(7):1197-203. PubMed ID: 12105241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of fish-oil dietary supplement on the progression of mesangial IgA glomerulonephritis.
    Cheng IK; Chan PC; Chan MK
    Nephrol Dial Transplant; 1990; 5(4):241-6. PubMed ID: 2113220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ω-3 fatty acids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials.
    Liu LL; Wang LN
    Clin Nephrol; 2012 Feb; 77(2):119-25. PubMed ID: 22257542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. n-3 Fatty acids and their role in nephrologic practice.
    Donadio JV
    Curr Opin Nephrol Hypertens; 2001 Sep; 10(5):639-42. PubMed ID: 11496058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
    Branten AJ; Klasen IS; Wetzels JF
    Clin Nephrol; 2002 Oct; 58(4):267-74. PubMed ID: 12400841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent.
    Hogg RJ; Fitzgibbons L; Atkins C; Nardelli N; Bay RC;
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1167-72. PubMed ID: 17699343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term efficacy and safety of immunosuppressive therapy on the progression of IgA nephropathy: a meta-analysis of controlled clinical trials with more than 5-year follow-up.
    Tian L; Shao X; Xie Y; Wang L; Wang Q; Che X; Ni Z; Mou S
    Expert Opin Pharmacother; 2015 Jun; 16(8):1137-47. PubMed ID: 25892092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. n-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis.
    Pestka JJ
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):251-8. PubMed ID: 20189790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-year GFR slope and long-term renal outcome in IgA nephropathy.
    Lee K; Shin J; Park J; Hwang S; Jang HR; Huh W; Kwon GY; Kim YG; Oh HY; Lee JE; Kim DJ
    Eur J Clin Invest; 2018 Jun; 48(6):e12936. PubMed ID: 29660832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary Perilla seed oil supplement increases plasma omega-3 polyunsaturated fatty acids and ameliorates immunoglobulin A nephropathy in high immunoglobulin A strain of ddY mice.
    Sakurai K; Asahi K; Kanesaki Y; Hayashi Y; Asai J; Yuza T; Watanabe K; Katoh T; Watanabe T
    Nephron Exp Nephrol; 2011; 119(2):e33-9. PubMed ID: 21734409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.